Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Endocrine-Related Cancer
|
March 2, 2023
Deiodinases in thyroid tumorigenesis
Maria Angela De Stefano, Tommaso Porcelli, Martin Schlumberger, et al.
Endocrinology
|
February 4, 2021
Deiodinases and Cancer
Annarita Nappi, Maria Angela De Stefano, Monica Dentice, et al.
Molecular and Cellular Endocrinology
|
June 21, 2017
Thyroid hormone signaling and deiodinase actions in muscle stem/progenitor cells
Raffaele Ambrosio, Maria Angela De Stefano, Daniela Di Girolamo, et al.
The Lancet. Diabetes & Endocrinology
|
July 17, 2025
The unique signature of tyrosine kinase inhibitor-induced hypothyroidism
Tommaso Porcelli, Maria Angela De Stefano, Cristina Luongo, et al.
Metabolites
|
November 25, 2021
Thyroid Hormone Action in Muscle Atrophy
Maria Angela De Stefano, Raffaele Ambrosio, Tommaso Porcelli, et al.
Endocrine-Related Cancer
|
May 1, 2025
FT3 and FT3/FT4 ratio are decreased and not compensated by levothyroxine treatment in TKI-treated thyroid cancer patients
Tommaso Porcelli, Cristina Luongo, Anna Cerbone, et al.
Endocrine-Related Cancer
|
March 6, 2023
Type 2 deiodinase is expressed in anaplastic thyroid carcinoma and its inhibition causes cell senescence
Maria Angela De Stefano, Tommaso Porcelli, Raffaele Ambrosio, et al.
Nucleic Acids Research
|
February 12, 2013
Epigenetic control of type 2 and 3 deiodinases in myogenesis: role of Lysine-specific Demethylase enzyme and FoxO3
Raffaele Ambrosio, Valentina Damiano, Annarita Sibilio, et al.
Endocrinology
|
March 10, 2025
Type 2 Deiodinase Promotes Fatty Adipogenesis in Muscle Fibroadipogenic Progenitors From Adult Male Mice
Cristina Luongo, Daniela Di Girolamo, Raffaele Ambrosio, et al.
European Thyroid Journal
|
January 22, 2025
Did selective kinase inhibitors change the management of patients with radioiodine-refractory thyroid cancer?
Tommaso Porcelli, Cristina Luongo, Anna Cerbone, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Endocrine-Related Cancer
|
March 2, 2023
Deiodinases in thyroid tumorigenesis
Maria Angela De Stefano, Tommaso Porcelli, Martin Schlumberger, et al.
Endocrinology
|
February 4, 2021
Deiodinases and Cancer
Annarita Nappi, Maria Angela De Stefano, Monica Dentice, et al.
Molecular and Cellular Endocrinology
|
June 21, 2017
Thyroid hormone signaling and deiodinase actions in muscle stem/progenitor cells
Raffaele Ambrosio, Maria Angela De Stefano, Daniela Di Girolamo, et al.
The Lancet. Diabetes & Endocrinology
|
July 17, 2025
The unique signature of tyrosine kinase inhibitor-induced hypothyroidism
Tommaso Porcelli, Maria Angela De Stefano, Cristina Luongo, et al.
Metabolites
|
November 25, 2021
Thyroid Hormone Action in Muscle Atrophy
Maria Angela De Stefano, Raffaele Ambrosio, Tommaso Porcelli, et al.
Endocrine-Related Cancer
|
May 1, 2025
FT3 and FT3/FT4 ratio are decreased and not compensated by levothyroxine treatment in TKI-treated thyroid cancer patients
Tommaso Porcelli, Cristina Luongo, Anna Cerbone, et al.
Endocrine-Related Cancer
|
March 6, 2023
Type 2 deiodinase is expressed in anaplastic thyroid carcinoma and its inhibition causes cell senescence
Maria Angela De Stefano, Tommaso Porcelli, Raffaele Ambrosio, et al.
Nucleic Acids Research
|
February 12, 2013
Epigenetic control of type 2 and 3 deiodinases in myogenesis: role of Lysine-specific Demethylase enzyme and FoxO3
Raffaele Ambrosio, Valentina Damiano, Annarita Sibilio, et al.
Endocrinology
|
March 10, 2025
Type 2 Deiodinase Promotes Fatty Adipogenesis in Muscle Fibroadipogenic Progenitors From Adult Male Mice
Cristina Luongo, Daniela Di Girolamo, Raffaele Ambrosio, et al.
European Thyroid Journal
|
January 22, 2025
Did selective kinase inhibitors change the management of patients with radioiodine-refractory thyroid cancer?
Tommaso Porcelli, Cristina Luongo, Anna Cerbone, et al.
Page
of 3